|
|
|
|
|
1.
3592 Accesses
|
DNA vaccines: improving expression of antigens
Helen S Garmory, Katherine A Brown, Richard W Titball Genetic Vaccines and Therapy 2003, 1:2 (16 September 2003)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
2.
3303 Accesses
|
Antiviral drugs against hepatitis C virus
Sidra Rehman, Usman A Ashfaq, Tariq Javed Genetic Vaccines and Therapy 2011, 9:11 (23 June 2011)
Abstract | Full text | PDF | PubMed
|
|
|
3.
2987 Accesses
|
Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan
Irshad-ur Rehman, Muhammad Idrees, Muhammad Ali, Liaqat Ali, Sadia Butt, Abrar Hussain, Haji Akbar, Samia Afzal Genetic Vaccines and Therapy 2011, 9:2 (6 January 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
4.
2938 Accesses
|
DNA vaccine constructs against enterovirus 71 elicit immune response in mice
Wong Tung, Sazaly Bakar, Zamberi Sekawi, Rozita Rosli Genetic Vaccines and Therapy 2007, 5:6 (19 April 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
5.
2820 Accesses
|
DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants
Dana Pokorna, Ivonne Rubio, Martin Müller Genetic Vaccines and Therapy 2008, 6:4 (7 February 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
The tattoo delivery of DNA vaccines is cost effective, induces a greater immune response, and is a more efficient delivery strategy for laboratory studies than intramuscular injection.
|
|
|
6.
2669 Accesses
|
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery
Donald S Anson Genetic Vaccines and Therapy 2004, 2:9 (13 August 2004)
Abstract | Full text | PDF | PubMed
|
|
|
7.
2424 Accesses
|
DNA vaccines: designing strategies against parasitic infections
Catherine Ivory, Kris Chadee Genetic Vaccines and Therapy 2004, 2:17 (3 December 2004)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
8.
2344 Accesses
|
In-vitro model systems to study Hepatitis C Virus
Usman Ashfaq, Shaheen N Khan, Zafar Nawaz, Sheikh Riazuddin Genetic Vaccines and Therapy 2011, 9:7 (6 April 2011)
Abstract | Full text | PDF | PubMed
|
|
|
9.
2179 Accesses
|
Establishment of stable Huh-7 cell lines expressing various hepatitis C virus genotype 3a protein: an in-vitro testing system for novel anti-HCV drugs
Sadia Butt, Muhammad Idrees, Irshad-ur Rehman, Liaqat Ali, Abrar Hussain, Muhammad Ali, Naveed Ahmed, Sana Saleem, Madiha Fayyaz Genetic Vaccines and Therapy 2011, 9:12 (28 June 2011)
Abstract | Full text | PDF | PubMed
|
|
|
10.
2041 Accesses
|
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas
Jean-Philippe Carralot, Benjamin Weide, Oliver Schoor, Jochen Probst, Birgit Scheel, Regina Teufel, Ingmar Hoerr, Claus Garbe, Hans-Georg Rammensee, Steve Pascolo Genetic Vaccines and Therapy 2005, 3:6 (22 August 2005)
Abstract | Full text | PDF | PubMed
|
|
|
11.
1977 Accesses
|
A comparison of multiple shRNA expression methods for combinatorial RNAi
Glen J Mcintyre, Allison J Arndt, Kirsten M Gillespie, Wendy M Mak, Gregory C Fanning Genetic Vaccines and Therapy 2011, 9:9 (17 April 2011)
Abstract | Full text | PDF | PubMed
|
|
|
12.
1972 Accesses
|
Comparative analysis of macrophage associated vectors for use in genetic vaccine
Mohammad Ahsan, Milind M Gore Genetic Vaccines and Therapy 2011, 9:10 (18 June 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
13.
1896 Accesses
|
HCV entry receptors as potential targets for siRNA-based inhibition of HCV
Shah Jahan, Baila Samreen, Saba Khaliq, Bushra Ijaz, Mahwish Khan, Muhammad Siddique, Waqar Ahmad, Sajida Hassan Genetic Vaccines and Therapy 2011, 9:15 (6 September 2011)
Abstract | Full text | PDF | PubMed
|
|
|
14.
1805 Accesses
|
Double suicide genes driven by kinase domain insert containing receptor promoter selectively kill human lung cancer cells
Junrong Ma, Mi Li, Longyong Mei, Qinghua Zhou, Lunxu Liu, Xijie Yu, Guowei Che Genetic Vaccines and Therapy 2011, 9:6 (22 March 2011)
Abstract | Full text | PDF | PubMed
|
|
|
15.
1802 Accesses
|
Recombinant λ-phage nanobioparticles for tumor therapy in mice models
Amir Ghaemi, Hoorieh Soleimanjahi, Pooria Gill, Zuhair Hassan, Soodeh Razeghi M Jahromi, Farzin Roohvand Genetic Vaccines and Therapy 2010, 8:3 (12 May 2010)
Abstract | Full text | PDF | PubMed
|
|
|
16.
1791 Accesses
|
Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant
Babak Jalilian, Abdul Omar, Mohd Bejo, Noorjahan Alitheen, Mehdi Rasoli, Sohkichi Matsumoto Genetic Vaccines and Therapy 2010, 8:4 (24 May 2010)
Abstract | Full text | PDF | PubMed
|
|
|
17.
1772 Accesses
|
Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems
Ming Q Wei, Ruimei Ren, David Good, Jozef Anné Genetic Vaccines and Therapy 2008, 6:8 (17 February 2008)
Abstract | Full text | PDF | PubMed
|
|
|
18.
1701 Accesses
|
In vivo gene targeting of IL-3 into immature hematopoietic cells through CD117 receptor mediated antibody gene delivery
Alain Chapel, Olivier Deas, Morad Bensidhoum, Sabine François, Moubarak Mouiseddine, Pascal Poncet, Antoine Dürrbach, Jocelyne Aigueperse, Patrick Gourmelon, Norbert C Gorin, François Hirsch, Dominique Thierry Genetic Vaccines and Therapy 2004, 2:16 (27 October 2004)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
19.
1691 Accesses
|
A DNA vaccine against tuberculosis based on the 65 kDa heat-shock protein differentially activates human macrophages and dendritic cells
Luís H Franco, Pryscilla F Wowk, Célio L Silva, Ana PF Trombone, Arlete AM Coelho-Castelo, Constance Oliver, Maria C Jamur, Edson L Moretto, Vânia LD Bonato Genetic Vaccines and Therapy 2008, 6:3 (21 January 2008)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
A DNA vaccine against tuberculosis, effective in mice, is shown to stimulate the human immune response, providing clues for new strategies in human immunotherapy.
|
|
|
20.
1685 Accesses
|
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Ambreen G Muazzam, Saleem Qureshi, Atika Mansoor, Lubna Ali, Musarrat Iqbal, Saima Siddiqi, Khalid M Khan, Kehkashan Mazhar Genetic Vaccines and Therapy 2011, 9:14 (6 September 2011)
Abstract | Full text | PDF | PubMed
|
|
|
21.
1580 Accesses
|
Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism
Douglas E Dylla, Litao Xie, Daniel E Michele, Stefan Kunz, Paul B McCray Genetic Vaccines and Therapy 2011, 9:8 (8 April 2011)
Abstract | Full text | PDF | PubMed
|
|
|
22.
1512 Accesses
|
Dietary restriction abrogates antibody production induced by a DNA vaccine encoding the mycobacterial 65 kDa heat shock protein
Larissa Ishikawa, Thaís França, Fernanda Chiuso-Minicucci, Sofia Zorzella-Pezavento, Nelson Marra, Paulo Pereira, Célio Silva, Alexandrina Sartori Genetic Vaccines and Therapy 2009, 7:11 (16 July 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
23.
1487 Accesses
|
Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice
Agnieszka Jazwa, Paulina Kucharzewska, Justyna Leja, Anna Zagorska, Aleksandra Sierpniowska, Jacek Stepniewski, Magdalena Kozakowska, Hevidar Taha, Takahiro Ochiya, Rafal Derlacz, Elisa Vahakangas, Seppo Yla-Herttuala, Alicja Jozkowicz, Jozef Dulak Genetic Vaccines and Therapy 2010, 8:6 (30 August 2010)
Abstract | Full text | PDF | PubMed
|
|
|
24.
1484 Accesses
|
Optimised electroporation mediated DNA vaccination for treatment of prostate cancer
Sarfraz Ahmad, Garrett Casey, Paul Sweeney, Mark Tangney, Gerald C O'Sullivan Genetic Vaccines and Therapy 2010, 8:1 (5 February 2010)
Abstract | Full text | PDF | PubMed
|
|
|
25.
1480 Accesses
|
Electroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells
Nina Iversen, Baard Birkenes, Kari Torsdalen, Srdjan Djurovic Genetic Vaccines and Therapy 2005, 3:2 (18 April 2005)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|